Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/133255
DC FieldValue
dc.titleIntrauterine administration of prostaglandin 15 (S) 15 methyl E2 methyl ester in the management of patients with a hydatidiform mole
dc.contributor.authorKarim, S.M.M.
dc.contributor.authorRatnam, S.S.
dc.contributor.authorChoo, H.T.
dc.date.accessioned2016-12-19T06:48:44Z
dc.date.available2016-12-19T06:48:44Z
dc.date.issued1974
dc.identifier.citationKarim, S.M.M., Ratnam, S.S., Choo, H.T. (1974). Intrauterine administration of prostaglandin 15 (S) 15 methyl E2 methyl ester in the management of patients with a hydatidiform mole. J.OBSTET.GYNAEC.BRIT.CWLTH 81 (8) : 650-651. ScholarBank@NUS Repository.
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/133255
dc.description.abstractIntrauterine administration of Prostaglandin 15 (S) 15 methyl E2 methyl ester was successfully used to evacuate the uterus in 20 patients with a hydatidiform mole. 15 patients aborted with a single intrauterine dose of 30 μg of the analogue and 5 were given a second dose 8 hr later. The interval between the first dose to expulsion of the hydatidiform mole ranged from 2 3/4 hr to 16 hr with a mean of 9 hr 4 min for the 20 patients.
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentOBSTETRICS & GYNAECOLOGY
dc.description.sourcetitleJ.OBSTET.GYNAEC.BRIT.CWLTH
dc.description.volume81
dc.description.issue8
dc.description.page650-651
dc.description.codenJOGBA
dc.identifier.isiutNOT_IN_WOS
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Page view(s)

17
checked on Jul 19, 2019

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.